NCT04832776 2021-04-06FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver MetastasesFudan UniversityPhase 2 Unknown160 enrolled
NCT04003792 2020-10-20Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.Rabin Medical CenterPhase 2 Unknown49 enrolled